• News
  • eNews
  • Connections
  • Specials
  • Videos
  • Events
  • Event Calendar
Airnov launches high barrier EVOH bottles for healthcare packaging
Source:Adsale Plastics Network    Editor:JK    Date:22.Dec.2020

Airnov Healthcare Packaging, a global leader in shelf-life preservation solutions to protect pharmaceutical, nutraceutical and diagnostic products from moisture and oxygen, is introducing its new brand, OXYNOV. Applicable for High Protective Barrier Bottles, OXYNOV offers protection for pharmaceutical, nutraceutical and probiotic products.


The OXYNOV Barrier Bottles utilize extrusion-blow-molding (EBM) technology creating a 6-layer bottle with ethylene vinyl alcohol (EVOH) which offers the high barrier to oxygen and moisture available on the market for this packaging category.


OXYNOV Barrier Bottles New branding introduction in Airnov.

The OXYNOV bottles are rigid containers to be used on automated filling lines for a fast, reliable output, and do not shrink when bottles are used in conjunction with oxygen absorbers.


The OXYNOV bottle is the latest brand in Airnov’s oxygen protective solutions which, when combined with oxygen absorbers, offers the ideal product to avoid the degradation of oxygen sensitive products such as drugs, proteins or probiotics. Airnov produces OXYNOV bottles in a range of sizes from 40cc to 400cc.


“After introducing our new company name in February this year we are continuing to update and evolve some Airnov category products to grow our core business of healthcare packaging solutions. It’s been a wonderful journey along this process to create OXYNOV,” said Stephane Rault, global product line manager.


OXYNOV not only protects against oxygen, it guarantees protection from moisture and UV. The OXYNOV bottles are delivered to customers in tight aluminum bags resulting in a 2-year shelf-life, are compliant with SP-400 regulation and may be used with standard screw cap and child resistant closures as well as US FDA, EU regulations and USP 38/NF 33 supplement 1<671>. Regulatory statements are available upon request and are registered in a Drug Master File.



Leave A Comment


All Comments

Articles You'll Like